Dino Wu


Wu, Dino

Dino Wu represents sell-side and buy-side clients in negotiating trading agreements, including derivatives master agreements and confirmations, futures and options agreements, OTC clearing agreements, prime brokerage agreements, term commitments, netting arrangements, custody and account control agreements, electronic services agreements, master repurchase agreements and securities lending agreements. Mr. Wu has extensive experience with all agreements relating to futures and derivatives, cleared and uncleared, including ISDA master agreements, central clearing documentation, segregated collateral arrangements and confirmations of equity, credit, fixed income, foreign exchange and commodities derivative transactions. He also regularly assists clients in complying with regulations relating to derivatives, including Dodd-Frank and EMIR.

Mr. Wu also represents corporate clients in their equity derivatives transactions, including accelerated share repurchases and forward share repurchases and sales, call spreads and capped calls. In addition, he advises corporate clients regarding ISDA master agreements, interest rate swaps and foreign exchange hedging.

Mr. Wu previously was a corporate associate at Davis Polk & Wardwell in New York, where he represented broker-dealers, hedge funds, investment advisers, and other financial institutions in corporate, securities, regulatory and compliance matters.

Upon graduating from law school, Mr. Wu completed clerkships with both the Honorable Jane R. Roth of the United States Court of Appeals for the Third Circuit and the Honorable Mark L. Wolf of the United States District Court for the District of Massachusetts.


Publications & News


November 9, 2016

CFTC Revises Proposed Reg AT

The Commodity Futures Trading Commission on November 3, 2016, proposed revisions  to proposed Regulation Automated Trading (Reg AT). Reg AT, if adopted, will broadly affect those in the futures industry who trade electronically, imposing new registration and supervision requirements on algorithmic traders.

July 18, 2016

WilmerHale Advises Intercept Pharmaceuticals in $460M Public Offering

Intercept Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, has announced the closing of an underwritten public offering of $460 million aggregate principal amount of 3.25% convertible senior notes due 2023.

February 11, 2016

SEC Adopts Rules on Non-US Firms That “Arrange, Negotiate, or Execute” Security-Based Swaps in the US

The Securities and Exchange Commission (SEC) adopted rules that will affect firms operating in the global security-based swap market. Specifically, the SEC is requiring non-US firms that arrange, negotiate, or execute security-based swaps using personnel located in the United States to include those security-based swaps in their calculations of whether they reach the threshold requiring security-based swap dealer registration.

January 26, 2016

2015 CFTC Year-in-Review, and a Look Forward

CFTC continues to bring high-profile, large-penalty enforcement cases; begins bringing cases to enforce Dodd-Frank Act implementing regulations; and embarks on post-Dodd-Frank Act regulatory initiatives.

December 15, 2015

CFTC Proposes “Regulation AT” for Automated Trading

On November 24, 2015, the Commodity Futures Trading Commission (CFTC or Commission) proposed a new regulatory regime for automated trading on US designated contract markets (DCM) (Regulation AT or the proposal).

September 29, 2015

CFTC Updates Position Limits Rule

On September 22, 2015, the Commodity Futures Trading Commission (CFTC or Commission) unanimously approved the publication of a “supplemental” proposed rule on position limits. The supplemental proposal would modify the requirements in the proposed rules regarding the aggregation of positions subject to the Commission’s speculative position limits. Specifically, the proposal would modify the eligibility criteria and simplify the process for claiming an exemption from the aggregation requirements for owners of more than 50 percent of another entity.

April 30, 2015

SEC Proposes Rules to Oversee Non-US Firms’ Swap Activity in the United States

On April 29, 2015, the US Securities and Exchange Commission proposed new rules to enhance its oversight of non-US firms’ security-based swap activity in the United States.

May 1, 2014

CFTC Issues Oral Recordkeeping No-Action Relief to Asset Managers

On April 25, 2014, the Commodity Futures Trading Commission (CFTC) extended time-limited no-action relief for certain asset manager members of swap execution facilities (SEFs) and designated contract markets (DCMs) from the oral recordkeeping requirement of CFTC Regulation 1.35(a) in connection with the execution of swaps.

July 1, 2013

Thermo Fisher Completes $2.53 Billion Common Stock Offering

A team of WilmerHale transactional lawyers represented Thermo Fisher Scientific Inc. in its recently completed $2.53 billion underwritten public offering of its common stock made in connection with the forward sale agreements described below.

January 9, 2013

The New Swaps Regime: A Primer for Nonfinancial Companies

Speaking Engagements


Skip Navigation Links.


JD, cum laude, Harvard Law School, 1997, Notes Editor and Bluebook Editor, Harvard Law Review

AB, Philosophy, Harvard University, 1994

Bar Admissions

New York


The Hon. Jane R. Roth, US Court of Appeals for the Third Circuit, 1998 - 1999

The Hon Mark L. Wolf, US District Court for the District of Massachusetts, 1997 - 1998

Skip Navigation Links.